SLNO Live signaler | Maksimer profitt med Getagraph.com

SELG 111857 min ago

@ $47.17

Utstedt: 14 feb 2024 @ 19:07

Avkastning: 0.78%

Forrige signal: feb 12 - 19:41

Forrige signal: Kjøp

Avkastning: -2.41 %

Live Chart Being Loaded With Signals

Commentary (1 mai 2024 @ 22:00):

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases...

Stats
Dagens volum	433 148
Gjennomsnittsvolum	378 585
Markedsverdi	1.59B
EPS	$0 ( 2024-03-19 )
Neste inntjeningsdato	( $-0.270 ) 2024-05-07
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-20.14
ATR14	$0.151 (0.32%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-29	Vivo Opportunity, Llc	Sell	750 000	Common Stock
2024-04-30	Vivo Opportunity, Llc	Sell	351 242	Common Stock
2024-04-22	Manning Meredith	Sell	128 000	Employee stock option (right to buy)
2024-04-22	Huang Michael F.	Sell	120 000	Employee stock option (right to buy)
2024-04-01	Yen Kristen	Sell	1 330	Common Stock

INSIDER POWER
-2.77
Last 99 transactions
Buy: 11 116 006 \| Sell: 11 241 097

Volum Korrelasjon

Lang: 0.19 (neutral)

Kort: -0.24 (neutral)

Signal:(38.021) Neutral

Soleno Therapeutics Inc Korrelasjon

10 Mest positive korrelasjoner
CVV	0.937
MDGL	0.929
EWCZ	0.928
EVCM	0.925
BNFT	0.92
DGHI	0.918
KIN	0.917
RIGL	0.912
EXFO	0.912
GIGM	0.912

10 Mest negative korrelasjoner
RIVN	-0.913
SOPA	-0.912
LUCD	-0.911
SNPX	-0.906
MTEX	-0.905
PIII	-0.902
OP	-0.899
SMMF	-0.898
ZENV	-0.889
JAN	-0.886

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Soleno Therapeutics Inc Korrelasjon - Valuta/Råvare

0.82
( strong )

0.85
( strong )

0.68
( moderate )

0.82
( strong )

0.52
( weak )

-0.86
( strong negative )

Soleno Therapeutics Inc Økonomi

Annual	2023
Omsetning:	$0
Bruttogevinst:	$-1.96M (0.00 %)
EPS:	$-2.36

FY	2023
Omsetning:	$0
Bruttogevinst:	$-1.96M (0.00 %)
EPS:	$-2.36

FY	2022
Omsetning:	$0
Bruttogevinst:	$-2.21M (0.00 %)
EPS:	$-2.42

FY	2021
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-7.40

Financial Reports:

No articles found.

Soleno Therapeutics Inc

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing Phase III clinical development program. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California.

Sanntidsoppdatering for Soleno Therapeutics Inc [SLNO]

Upcoming Earnings Alert